Challenges in the Management of Positive Fecal Occult Blood Tests

  • Sandhya K. Rao
  • Thad F. Schilling
  • Thomas D. Sequist
Original Article

Abstract

BACKGROUND

Many patients with a positive fecal occult blood test (FOBT) do not undergo follow-up evaluations.

OBJECTIVE

To identify the rate of follow-up colonoscopy following a positive FOBT and determine underlying reasons for lack of follow-up.

DESIGN

It is a retrospective chart review.

PARTICIPANTS

The subject group consisted of 1,041 adults with positive FOBTs within a large physician group practice from 2004 to 2006.

MEASUREMENTS

We collected data on reasons for ordering FOBT, presence of prior colonoscopy, completed evaluations, and results of follow-up tests. We fit a multivariable logistic regression model to identify predictors of undergoing follow-up colonoscopy.

RESULTS

Most positive FOBTs were ordered for routine colorectal cancer screening (76%), or evaluation of anemia (13%) or rectal bleeding (7%). Colonoscopy was completed in 62% of cases, with one-third of these procedures identifying a colorectal adenoma (29%) or cancer (4%). Factors associated with higher rates of follow-up colonoscopy included obtaining the FOBT for routine colorectal screening (odds ratio (OR) 1.59, 95% confidence interval (CI) 1.11–2.29) and consultation with gastroenterology (OR 1.99, 95% CI 1.46–2.72). Patients were less likely to undergo colonoscopy if they were older than 80 years old (OR 0.54, 95% CI 0.31–0.92), younger than 50 years old (OR 0.44, 95% CI 0.28–0.70), uninsured (OR 0.50, 95% CI 0.27–0.93), or had undergone colonoscopy within the prior five years (OR 0.32, 95% CI 0.23–0.44).

CONCLUSIONS

Clinical decisions and patient factors available at the time of ordering an FOBT impact performance of colonoscopy. Targeting physicians’ understanding of the use of this test may improve follow-up and reduce inappropriate use of this test.

KEY WORDS

colorectal cancer cancer screening quality of care risk management patient safety fecal occult blood test 

Notes

Acknowledgements

The authors would like to thank Amy Marston, BA for her efforts in data extraction and project management. This study was funded by a grant from the Harvard Risk Management Foundation. The funding agency played no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. Dr. Sequist had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis

Conflict of Interest

None of the authors have any conflicts of interest to disclose.

References

  1. 1.
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.PubMedCrossRefGoogle Scholar
  2. 2.
    Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71.PubMedCrossRefGoogle Scholar
  3. 3.
    Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7.PubMedGoogle Scholar
  6. 6.
    Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–81.PubMedCrossRefGoogle Scholar
  7. 7.
    United States Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129–31.Google Scholar
  8. 8.
    Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin. 2001;51:38–75.PubMedCrossRefGoogle Scholar
  9. 9.
    Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. A national survey of primary care physicians’ colorectal cancer screening recommendations and practices. Prev Med. 2003;36:352–62.PubMedCrossRefGoogle Scholar
  11. 11.
    Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296:2815–22.PubMedCrossRefGoogle Scholar
  12. 12.
    Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–58.PubMedGoogle Scholar
  13. 13.
    DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008;23:169–74.PubMedCrossRefGoogle Scholar
  14. 14.
    Use of colorectal cancer tests-United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008;57:253–8.Google Scholar
  15. 15.
    Levin B, Lieberman DA, McFarland B, et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008.Google Scholar
  16. 16.
    Levin B, Hess K, Johnson C. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests. Arch Intern Med. 1997;157:970–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Shields HM, Weiner MS, Henry DR, et al. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. Am J Gastroenterol. 2001;96:196–203.PubMedCrossRefGoogle Scholar
  18. 18.
    Baig N, Myers RE, Turner BJ, et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol. 2003;98:2078–81.PubMedCrossRefGoogle Scholar
  19. 19.
    Turner B, Myers RE, Hyslop T, et al. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med. 2003;18:357–63.PubMedCrossRefGoogle Scholar
  20. 20.
    Etzioni DA, Yano EM, Rubenstein LV, et al. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum. 2006;49:1002–10.PubMedCrossRefGoogle Scholar
  21. 21.
    Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006;15:1232–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst. 1999;91:1641–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med. 1997;126:811–22.PubMedGoogle Scholar
  24. 24.
    Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians’ methods for screening for fecal occult blood. Ann Intern Med. 2005;142:86–94.PubMedGoogle Scholar
  25. 25.
    Klabunde CN, Riley GF, Mandelson MT, Frame PS, Brown ML. Health plan policies and programs for colorectal cancer screening: a national profile. Am J Manag Care. 2004;10:273–9.PubMedGoogle Scholar
  26. 26.
    Charles RJ, Cooper GS, Wong RC, Sivak MV Jr., Chak A. Effectiveness of open-access endoscopy in routine primary-care practice. Gastrointest Endosc. 2003;57:183–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Ayanian JZ, Sequist TD, Zaslavsky AM, Johannes RS. Physician Reminders to Promote Surveillance Colonoscopy for Colorectal Adenomas: A Randomized Controlled Trial. J Gen Intern Med. 2008.Google Scholar
  28. 28.
    Sequist TD, Adams A, Zhang F, Ross-Degnan D, Ayanian JZ. Effect of quality improvement on racial disparities in diabetes care. Arch Intern Med. 2006;166:675–81.PubMedCrossRefGoogle Scholar
  29. 29.
    Pereira AG, Kleinman KP, Pearson SD. Leaving the practice: effects of primary care physician departure on patient care. Arch Intern Med. 2003;163:2733–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Sequist TD, Marshall R, Lampert S, Buechler EJ, Lee TH. Missed opportunities in the primary care management of early acute ischemic heart disease. Arch Intern Med. 2006;166:2237–43.PubMedCrossRefGoogle Scholar
  31. 31.
    Sequist TD, Fitzmaurice GM, Marshall R, Shaykevich S, Safran DG, Ayanian JZ. Physician performance and racial disparities in diabetes mellitus care. Arch Intern Med. 2008;168:1145–51.PubMedCrossRefGoogle Scholar
  32. 32.
    Poon EG, Gandhi TK, Sequist TD, Murff HJ, Karson AS, Bates DW. I wish I had seen this test result earlier!: Dissatisfaction with test result management systems in primary care. Arch Intern Med. 2004;164:2223–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Seeff LC, Manninen DL, Dong FB, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004;127:1661–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005;129:1151–62.PubMedCrossRefGoogle Scholar
  35. 35.
    Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care. 2005;43:939–44.PubMedCrossRefGoogle Scholar
  36. 36.
    Fisher DA, Judd L, Sanford NS. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol. 2005;100:2526–30.PubMedCrossRefGoogle Scholar
  37. 37.
    Capurso G, Baccini F, Osborn J, et al. Can patient characteristics predict the outcome of endoscopic evaluation of iron deficiency anemia: a multiple logistic regression analysis. Gastrointest Endosc. 2004;59:766–71.PubMedCrossRefGoogle Scholar
  38. 38.
    Lewis JD, Brown A, Localio AR, Schwartz JS. Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis. Ann Intern Med. 2002;136:99–110.PubMedGoogle Scholar
  39. 39.
    Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002;136:641–51.PubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2009

Authors and Affiliations

  • Sandhya K. Rao
    • 1
    • 2
    • 3
  • Thad F. Schilling
    • 2
  • Thomas D. Sequist
    • 1
    • 2
    • 4
  1. 1.Division of General Medicine and Primary CareBrigham and Women’s HospitalBostonUSA
  2. 2.Harvard Vanguard Medical AssociatesBostonUSA
  3. 3.Department of Ambulatory Care and PreventionHarvard Medical SchoolBostonUSA
  4. 4.Department of Health Care PolicyHarvard Medical SchoolBostonUSA

Personalised recommendations